CenterBook Partners »

Ligand Pharmaceuticals In shares owned by CenterBook Partners

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by CenterBook Partners from 13F filings

Historical chart of CenterBook Partners investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by CenterBook Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by CenterBook Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.4M 33k 73.10

More positions owned by CenterBook Partners

Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Starbucks Corporation (SBUX)
Nutrien (NTR)
Integral Ad Science Hldng (IAS)
Equinox Gold Corp equities (EQX)
Illumina (ILMN)
Meta Platforms Cl A (META)
Magna Intl Inc cl a (MGA)
Marqeta Class A Com (MQ)
Lithium Americas Argentina C Com Shs (LAAC)
At&t (T)
Microsoft Corporation (MSFT)
Dun & Bradstreet Hldgs (DNB)
Match Group (MTCH)

View all positions for CenterBook Partners

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Group
Henderson Group
Stephens Investment Management Group
Dimensional Fund Advisors
St. Denis J. Villere & Co
Geode Capital Management
Standard Life Aberdeen
Rice Hall James & Associates
Impax Asset Management Group
Morgan Stanley
Deutsche Bank Aktiengesellschaft
Chicago Capital
Northern Trust
Ashford Capital Management

View all funds holding Ligand Pharmaceuticals In